Nasal and ophthalmic delivery of aqueous corticosteroid solutions
US12370352B2 · kind B2 · utility
0Cited by
82References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 28, 2021 |
| Grant date | Jul 29, 2025 |
| Priority date | — |
| Expiry date | Mar 4, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/6951
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to methods of treating nasal and/or ophthalmic diseases, symptoms, or disorders that are therapeutically responsive to corticosteroid therapy by delivering aqueous solution formulations comprising a corticosteroid to nasal and ophthalmic tissues. The invention is also directed to methods, systems, devices, and compositions for delivering aqueous solution formulations comprising a corticosteroid and an antihistamine to nasal and ophthalmic tissues.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.